PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Overview: Conjunctivitis • Types of conjunctivitis • Signs and symptoms • Diagnosis PART 06: Pipeline analysis • AC-170 • AGN-229666 • DEXTENZA • SUN-1334H • Auriclosene • EBI-005 • FST-100 • SPL7013 • OPX-1 • AzaSite Xtra (ISV-405) • GD134 PART 07: Market landscape • Market overview • Market size and forecast • Conjunctivitis medication market in the US • Bacterial conjunctivitis medication market in the US • Viral conjunctivitis medication market in the US • Allergic conjunctivitis medication market in the US • Five forces analysis PART 08: Market segmentation based on condition type • Bacterial conjunctivitis medication • Viral conjunctivitis medication • Allergic conjunctivitis medication • Global bacterial conjunctivitis medication market • Global viral conjunctivitis medication market • Global allergic conjunctivitis medication market PART 09: Geographical segmentation • Geographical segmentation of global conjunctivitis medication market • Conjunctivitis medication market in the Americas • Conjunctivitis medication market in EMEA • Conjunctivitis medication market in APAC PART 10: Market drivers • Increased exposure to chemicals and pollutants • Rising awareness of condition • Exploring specific treatment for viral conjunctivitis • Tentative approval of pipeline candidates PART 11: Impact of drivers PART 12: Market challenges • Patent expiry of medication • Contentment with existing therapies • Adverse effects and limited efficacy of medication PART 13: Impact of drivers and challenges PART 14: Market trends • Strategic alliances and M&A • Use of combination therapies • Increased R&D PART 15: Vendor landscape • Competitive scenario • Market share analysis 2014 • Other prominent vendors PART 16: Key vendor analysis • Akorn • Alcon • Allergan • Bausch & Lomb PART 17: Appendix • List of abbreviations PART 18: Explore Technavio LOE Exhibit 01: Product offerings Exhibit 02: Causes of conjunctivitis Exhibit 03: Types of bacterial conjunctivitis Exhibit 04: Types of viral conjunctivitis Exhibit 05: Types of allergic conjunctivitis Exhibit 06: Signs and symptoms of common forms of conjunctivitis Exhibit 07: Medication used for treatment of conjunctivitis Exhibit 08: Global conjunctivitis market: Pipeline portfolio Exhibit 09: Global conjunctivitis market 2014-2019 ($ billions) Exhibit 10: Conjunctivitis market in the US 2014-2019 ($ billions) Exhibit 11: Percentage shares of conjunctivitis medication market in the US and outside the US Exhibit 12: Segmentation of conjunctivitis medication market in US based on condition type 2014 Exhibit 13: Bacterial conjunctivitis medication market in the US 2014-2019 ($ millions) Exhibit 14: Viral conjunctivitis medication market in the US 2014-2019 ($ millions) Exhibit 15: Allergic conjunctivitis medication market in the US 2014-2019 ($ millions) Exhibit 16: Conjunctivitis market in US: YoY growth and revenue based on condition type 2014-2019 Exhibit 17: Five forces analysis Exhibit 18: Segmentation of global conjunctivitis medication market based on condition type Exhibit 19: Segmentation of global conjunctivitis medication market based on condition type 2014 Exhibit 20: Global bacterial conjunctivitis medication market 2014-2019 ($ billions) Exhibit 21: Global viral conjunctivitis medication market 2014-2019 ($ millions) Exhibit 22: Global allergic conjunctivitis medication market 2014-2019 ($ billions) Exhibit 23: Global conjunctivitis medication market: YoY growth and revenue based on condition type 2014-2019 Exhibit 24: Geographical segmentation of global conjunctivitis medication market 2014 Exhibit 25: Conjunctivitis medication market in the Americas 2014-2019 ($ billions) Exhibit 26: Conjunctivitis medication market in EMEA 2014-2019 ($ millions) Exhibit 27: Conjunctivitis medication market in APAC 2014-2019 ($ millions) Exhibit 28: YoY growth and revenue of global conjunctivitis medication market by region 2014-2019 Exhibit 29: Impact of drivers Exhibit 30: Impact of drivers and challenges Exhibit 31: YoY growth and revenue generated from sales of ophthalmic therapeutics 2011-2013 ($ millions) Exhibit 32: Akorn: Key takeaways Exhibit 33: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions) Exhibit 34: Percentage share of divisions of Alcon based on revenue 2014 Exhibit 35: Alcon: Key takeaways Exhibit 36: Allergan: Key takeaways Exhibit 37: Allergan: Business segmentation 2014 by revenue Exhibit 38: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 39: Allergan: Geographical segmentation by revenue 2014 Exhibit 40: Bausch & Lomb: Product categories

Akorn, Alcon, Allergan, Bausch & Lomb, Celsus Therapeutics, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Merck, Nicox, NovaBay, Ocular Therapeutix, Santen Pharmaceutical, Shire (Foresight biotherapeutics), Starpharma, Sun Pharma.